Equity Incentive Grant. On the Effective Date, subject to Board approval, Executive will be granted incentive stock options to purchase six hundred fifty thousand (650,000) shares of the Company’s common stock (the “Option”). The Option shall vest with respect one hundred sixty-two thousand five hundred (162,500) shares on each of the first, second, third and fourth anniversaries of the Effective Date, subject to the Executive’s continued employment with the Company on each such day. Employee shall be entitled to additional options and/or equity based awards as determined in the discretion of the Board or a committee thereof. All of the Executive's Options and any subsequent options and/or equity awards shall cease vesting as of the Date of Termination (defined below); provided that in the event of (i) Executive's termination for Good Reason (defined below) or (ii) termination of Executive's employment by the Company without Cause (defined below), Executive's Options and any subsequent options and/or equity awards will be deemed to have vested as of the Date of Termination with respect to that number of shares that would have vested had Executive's employment with the Company continued for a period of one (1) year after the Date of Termination; and provided, further, that if Executive's termination for Good Reason or the termination of Executive's employment by the Company without Cause occurs within six (6) months after the occurrence of a change of control of the Company (“Change of Control”), then all of Executive's Options and any subsequent options and/or equity awards will be deemed to have vested as of the Date of Termination. Change of Control is defined as: (x) a merger or consolidation of the Company in which the stockholders of the Company immediately prior to such transaction would own, in the aggregate, less than fifty percent (50%) of the total combined voting power of all classes of capital stock of the surviving entity normally entitled to vote for the election of directors of the surviving entity or (y) the sale by the Company of all or substantially all the Company's assets in one transaction or in a series of related transactions. The Option will be issued from the existing Company option plan and will be subject to and governed by such plan. The Executive shall also be entitled to any other rights and benefits and subject to any other obligations with respect to option awards, to the extent and upon the terms provided in the employee option plan or any agreeme...
Equity Incentive Grant. On the Employment Date, Executive will receive (i) a restricted stock award (the “Restricted Stock Award”) as set forth in the Restricted Stock Agreement of even date herewith and (ii) a restricted stock unit award (the “Restricted Stock Unit Award”) as set forth in the Restricted Stock Unit Agreement of even date herewith. The Executive will receive a customary income tax “gross-up” only with respect to the Restricted Stock Award at a rate of 35%.
Equity Incentive Grant. PSUs: 5,000 performance based restricted stock units, to be granted on January 8, 2021 and to vest thereafter on January 8, 2022, subject to the achievement of defined goals established by the Compensation Committee of the Board. TXRH Executive Employment Agreement – XXXXXXXX
Equity Incentive Grant. The Executive shall further be entitled to receive, and the Company will grant to Executive an Equity Incentive Grant as follows: Ten-year Options to purchase 400,000 shares of Common Stock (“Company Options”) at an exercise price equal to the fair market value on the grant date. Such Company Options shall vest pro rata equally at each of the first four (4) annual anniversaries of this Agreement. For the avoidance of doubt vesting shall be as follows: 100,000 shares on September 1, 2022 100,000 shares on September 1, 2023 100,000 shares on September 1, 2024 100,000 shares on September 1, 2025 In the event that this Agreement has been terminated by the Company without Cause in accordance with Section 2.7(a) within three (3) months from the Commencement Date or by the Executive at any time after the Commencement Date for any reason other than Good Reason in accordance with Section 2.7(d), notwithstanding the terms of the Newgioco Group, Inc 2018 Equity Incentive Plan and any amendment thereto or any applicable award agreement, the Equity Incentive Grant will vest on a monthly pro rata basis from the Commencement Date up to the Termination Date and Executive shall forfeit that portion of the Equity Incentive Grant not vested as of the Termination Date. In the event that this Agreement has been terminated by the Company without Cause in accordance with Section 2.7(a) after three (3) months and one day from the Commencement Date, by Executive at any time after the Commencement Date for Good Reason in accordance with such Section 2.7(a) or by the Company by reason of the Disability or death of the Executive in accordance with Section 2.7(c), notwithstanding the terms of the Newgioco Group, Inc 2018 Equity Incentive Plan and any amendment thereto or any applicable award agreement, the Equity Incentive Grant vesting period will be accelerated to the Termination Date. If this Agreement has been terminated by the Company for Cause in accordance with Section 2.7(b), Executive shall forfeit the Equity Incentive Grant not vested as of the Termination Date. Executive shall have a period of three (3) months from such Termination Date to exercise Company Options vested as of such Termination Date.
Equity Incentive Grant. From time to time, the Parent Board may consider the Executive’s eligibility for and may award the Executive equity-based incentive awards, subject to the applicable plan, written award agreement and other documentation that the Parent Board may implement.
Equity Incentive Grant. On the date of the Effective Date, Executive will be granted non-qualified stock options under the Neurotrope, Inc. 2013 Equity Incentive Plan (the “Incentive Plan”) to purchase two hundred fifty thousand (250,000) shares of Neurotrope’s common stock (the “Options”). Each of the Options shall have an exercise price equal to the closing price of Neurotrope’s common stock on the OTCBB on the Effective Date, which shall be Executive’s date of hire and shall vest at a rate of 20% per year for five (5) years commencing with the first anniversary of the date of grant (i.e., with respect to fifty thousand (50,000) shares on each anniversary of the Effective Date over five (5) years). The Options shall cease vesting as of the Date of Termination (as defined below). Notwithstanding the foregoing, in the event a Change in Control (as such term is defined in the Incentive Plan) occurs while Executive remains employed by the Company, the unvested Options shall, as the Administrator of the Incentive Plan determines, be assumed or an equivalent option or right substituted by the successor corporation or a Parent or Subsidiary of the successor corporation, or in the event that the successor corporation does not assume or substitute for the Options, the Executive will fully vest in and have the right to exercise all of his outstanding Options.
Equity Incentive Grant. The Company shall grant to Brackpool concurrently with the execution of this Agreement 60,000 shares of common stock pursuant to the Company's 2007 Management Equity Incentive Plan (the "2007 Plan") which shares shall, for purposes of the 2007 Plan, be deemed to be Deferred Stock (as defined in the 2007 Plan) subject to immediate vesting upon execution of this Agreement.
Equity Incentive Grant. Contingent upon Neurotrope, Inc.’s successful completion of a financing transaction pursuant to which it raises at least ten million dollars ($10,000,000)(the “Financing Transaction”) in direct gross proceeds to the Company during the first eighteen (18) months of the Employment Term, Neurotrope, Inc. shall grant to Executive a non-qualified stock option exercisable for 100,000 shares of common stock of Neurotrope, Inc. (the “Financing Option”). The Financing Option will be issued to Executive on the date of the closing of the applicable Financing Transaction (assuming Executive remains employed under this Agreement as the President and Chief Executive Officer of the Company as of such date), will be fully vested as of the date of the grant, and will have an exercise price per share equal to the price per share paid by investors for securities of the Neurotrope, Inc. in the applicable Financing Transaction, and will have an exercise period of ten (10) years from the date of grant which is not reduced by any termination of employment or services.
Equity Incentive Grant. The Company shall grant to Shaheen concurrently with the execution of this Agreement 30,000 shares of common stock pursuant to the Company's 2007 Management Equity Incentive Plan (the "2007 Plan") which shares shall, for purposes of the 2007 Plan, be deemed to be Deferred Stock (as defined in the 2007 Plan) subject to immediate vesting upon execution of this Agreement.
Equity Incentive Grant. The Executive received a grant of an option to purchase shares of Parent common stock (the “Option”) pursuant to that Nonqualified Stock Option Award Agreement dated as of March 31, 2010 by and between the Executive and the Parent and such Option shall be governed by the terms and conditions in such Nonqualified Stock Option Award Agreement. From time to time, the Parent Board may consider the Executive’s eligibility for and may award the Executive additional equity-based incentive awards, subject to the applicable plan, written award agreement and other documentation that the Parent Board may implement or require.
